Glenmark Pharmaceuticals Ltd

GLENMARK06 Nov 2024
Pharmaceuticals
+38.60 (+2.24%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Glenmark Pharmaceuticals Ltd
Glenmark Pharmaceuticals Ltd
Pharmaceuticals
GLENMARK06 Nov 2024
+38.60 (+2.24%)
1D
1M
6M
1Y
5Y
All

Glenmark Pharmaceuticals Ltd - Share Price & Details

Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
128.36%
Upper Circuit
Lower Circuit
P/E TTM
30.09
P/B Ratio
2.12
Traded Value(Cr)
0.76
EPS TTM
57.32
Book value
Dividend
0.14%

Invest in Glenmark Pharmaceuticals Ltd at ZERO Brokerage for 30 days

Reports

How to buy Glenmark Pharmaceuticals Ltd shares on nse?

To buy Glenmark Pharmaceuticals Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Glenmark Pharmaceuticals Ltd share price today?

The Glenmark Pharmaceuticals Ltd shares price on nse is Rs.1763.75 today.

What is the market cap of Glenmark Pharmaceuticals Ltd shares on NSE ?

The company has a market capitalization of Rs.48681.69Cr

What is the PE & PB ratio of Glenmark Pharmaceuticals Ltd shares ?

PE is 30.09 and PB is 2.12

What is the 52 Week High and Low of Glenmark Pharmaceuticals Ltd shares?

Glenmark Pharmaceuticals Ltd stock price high: Rs.1830.95 Glenmark Pharmaceuticals Ltd stock price low: Rs.722.1

How has the GLENMARK share price performed in the past year?

In April 2022, the huge pharmaceutical GLENMARK’s share price was in the region of Rs. 478. By June, it had dipped to the late 300 levels and never significantly went up till November. Highs were felt in December, and February 2023, and now the stock is at the 448 level. 

Does GLENMARK pay dividends to its shareholders?

GLENMARK has a consistent track record of paying dividends to its loyal shareholders. In the recent past, the company has paid only final dividends, but interim dividends have been paid in the past as well. 

What is the dividend yield of GLENMARK?

The dividend yield of GLENMARK is 0.56% (March 2022). 

How does GLENMARK compare to its competitors in terms of share price?

Compared to popular competitors of GLENMARK, like Sun Pharma, Dr Reddy’s Labs, CIPLA, Torrent Pharma, Abbott India and others, the company’s share price is low at the moment (March 2023). Most of these companies have their share prices in the thousands, or late hundreds, whereas GLENMARK seems firmly poised on the mid-hundred mark. 

What is the company's debt-to-equity ratio?

The company’s debt-to-equity ratio is 0.22. 

What is the company's revenue and net income?

The revenue of GLENMARK is Rs. 3,463 crores (Q3 FY 2022-23)  and the net income is Rs. 291 crores (December 2022). 

How long has GLENMARK been in business?

GLENMARK started its foray into the pharmaceutical business with “Candid Cream”, a key dermatological drug, even in use now. The company started its business in 1977, headed by its Founder Emeritus, the late Gracias Saldanha. 

What is the company's history of share price performance?

The share price of GLENMARK has been somewhat stable in the last 4-5 years, not showing much volatility as other pharma stocks have. In 2018, the share was in the region of the 500 mark, peaking at nearly 700 in 2019. Then, with a gradual and slow downward movement, it dipped to the region of 199 in 2020, only to slowly rise to 662 in 2021. Since then, it has been in the range of between 400-500 and is steady now.